Skip to main content
logo
Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
6.07
+0.02 (0.33%)
At close: Apr 22, 2026, 4:00 PM EDT
6.12
+0.05 (0.81%)
After-hours: Apr 22, 2026, 7:21 PM EDT

Verastem Revenue

In the year 2025, Verastem had annual revenue of $30.91M with 209.14% growth. Verastem had revenue of $17.54M in the quarter ending December 31, 2025.

Revenue (ttm)
$30.91M
Revenue Growth
+209.14%
P/S Ratio
17.25
Revenue / Employee
$303,078
Employees
102
Market Cap
533.21M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202530.91M20.91M209.14%
Dec 31, 202410.00M--
Dec 31, 2023---
Dec 31, 20222.60M543.00K26.45%
Dec 31, 20212.05M-86.46M-97.68%
Dec 31, 202088.52M71.06M407.08%
Dec 31, 201917.46M-9.26M-34.67%
Dec 31, 201826.72M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Rigel Pharmaceuticals294.28M
ADC Therapeutics81.36M
Fulcrum Therapeutics80.00M
Armata Pharmaceuticals4.90M
Upstream Bio2.85M
Absci2.80M
Revenue Rankings

VSTM News

More News